SCHEMBL1154593

SCHEMBL1154593

CCCCCc1ccccc1-c1ccccc1-c1ccccc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.47
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NR1H2 P55055 1/20 0.46
NR1H3 Q13133 1/20 0.46
GCGR P47871 1/20 0.45
TLR8 Q9NR97 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 1/20 0.42
TSHR P16473 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27688479 0.98 LIPG (0.49) LIPGALDH1A1L3MBTL1NR1H2NR1H3
SCHEMBL2831772 0.96 LIPG (0.51) LIPGALDH1A1L3MBTL1NR1H2NR1H3
SCHEMBL27839133 0.96 LIPG (0.51) LIPGALDH1A1L3MBTL1NR1H2NR1H3
SCHEMBL27864911 0.96 LIPG (0.51) LIPGALDH1A1L3MBTL1NR1H2NR1H3
SCHEMBL27456996 0.95 ALDH1A1 (0.48) LIPGALDH1A1L3MBTL1NR1H2NR1H3
SCHEMBL27498291 0.93 ALDH1A1 (0.50) LIPGALDH1A1L3MBTL1NR1H2NR1H3
SCHEMBL1024526 0.87 LIPG (0.59) LIPGNR1H2NR1H3TLR8GPR3
SCHEMBL1646437 0.85 ALDH1A1 (0.54) ALDH1A1L3MBTL1GCGRSMN1; SMN2CNR1
SCHEMBL1921650 0.85 LIPG (0.62) LIPGNR1H2NR1H3GPR3ALOX5
SCHEMBL9619382 0.85 LIPG (0.62) LIPGNR1H2NR1H3GPR3ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888502-B2 Titanyl phthalocyanine processes and photoconductors thereof XEROX CORPORATION (US) 2011-02-15 US disclosed
US-7862967-B2 Photoconductors XEROX CORPORATION (US) 2011-01-04 US disclosed
US-7771909-B2 Titanyl phthalocyanine photoconductors XEROX CORPORATION (US) 2010-08-10 US disclosed
US-7553593-B2 Titanyl phthalocyanine photoconductors XEROX CORPORATION (US) 2009-06-30 US disclosed
US-7485398-B2 Titanyl phthalocyanine photoconductors XEROX CORPORATION (US) 2009-02-03 US disclosed
US-20090005555-A1 TITANYL PHTHALOCYANINE PROCESSES AND PHOTOCONDUCTORS THEREOF XEROX CORPORATION (US) 2009-01-01 US disclosed
US-20080286669-A1 Photoconductors XEROX CORPORATION. 2008-11-20 US disclosed
US-20080138726-A1 Titanyl phthalocyanine photoconductors XEROX CORPORATION 2008-06-12 US disclosed
US-20070298341-A1 Titanyl phthalocyanine photoconductors XEROX CORPORATION 2007-12-27 US disclosed
US-20070298342-A1 Titanyl phthalocyanine photoconductors XEROX CORPORATION 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005555-A1 TITANYL PHTHALOCYANINE PROCESSES AND PHOTOCONDUCTORS THEREOF CRYAA, PRKCA, PRKCI LIPG 3179/4885ALDH1A1 701/4885L3MBTL1 3075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.